The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorShanghai Mental Health Center

About this trial

The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.

Eligibility criteria

Qualifiers

In accordance with ICD-11 for Anxiety Disorders;

Between the ages of 18-60;

Completed at least 9 years of education;

Ability to use computers or smartphone;

Disqualifiers

With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;

Use of cognitive-enhancing medications within the past 6 months;

With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.

Trial design

Treatments tested in this trial

  • AI-based rehabilitation treatment combined with standard treatment
  • Treatment as Usual (TAU)

Treatment groups

158 Participants
are divided into 2 treatment groups

Sponsors and collaborators